VacPertagen

· BioNet-Asia Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VacPertagen, covering 2026-02-10 to 2026-03-05. Get the full timeline:

Most recent: EMA Authorised: VacPertagen (recombinant pertussis toxin;filamentous haemagglutinin) — BioNet Europe